Vanguard Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $429K | Buy |
|
|||||
|
2017
Q3 | $572K | Buy |
|
|||||
|
2017
Q2 | $756K | Sell |
|
|||||
|
2017
Q1 | $1.93M | Buy |
|
|||||
|
2016
Q4 | $520K | Sell |
|
|||||
|
2016
Q3 | $1.36M | Sell |
|
|||||
|
2016
Q2 | $1.85M | Sell |
|
|||||
|
2016
Q1 | $4.28M | Buy |
|
|||||
|
2015
Q4 | $10.4M | Buy |
|
|||||
|
2015
Q3 | $9.7M | Buy |
|
|||||
|
2015
Q2 | $22.4M | Buy |
|
|||||
|
2015
Q1 | $29.7M | Buy |
|
|||||
|
2014
Q4 | $22.2M | Sell |
|
|||||
|
2014
Q3 | $15.9M | Buy |
|
|||||
|
2014
Q2 | $18.5M | Buy |
|
|||||
|
2014
Q1 | $19.2M | Buy |
|
|||||
|
2013
Q4 | $15.6M | Buy |
|
|||||
|
2013
Q3 | $15.6M | Buy |
|
|||||
|
2013
Q2 | $13M | Buy |
|